| TOMANDLOVÁ, Marie, Martin PISKÁČEK, Vilém JURÁŇ, Marek SOVA, Martin SMRČKA, Václav VYBÍHAL, Pavel FADRUS, Tomáš KAZDA and Andrea KNIGHT. Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients. In Brain Tumour Conference 2022, 5-7 September 2022, London. 2022. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{2213743,
author = {Tomandlová, Marie and Piskáček, Martin and Juráň, Vilém and Sova, Marek and Smrčka, Martin and Vybíhal, Václav and Fadrus, Pavel and Kazda, Tomáš and Knight, Andrea},
booktitle = {Brain Tumour Conference 2022, 5-7 September 2022, London},
keywords = {PD-L1; B7-H3; galectin-9; plasma levels; glioblastoma},
language = {eng},
title = {Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients},
year = {2022}
}
TY - CONF
ID - 2213743
AU - Tomandlová, Marie - Piskáček, Martin - Juráň, Vilém - Sova, Marek - Smrčka, Martin - Vybíhal, Václav - Fadrus, Pavel - Kazda, Tomáš - Knight, Andrea
PY - 2022
TI - Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients
KW - PD-L1
KW - B7-H3
KW - galectin-9
KW - plasma levels
KW - glioblastoma
N2 - Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients - conference abstract.
ER -
TOMANDLOVÁ, Marie, Martin PISKÁČEK, Vilém JURÁŇ, Marek SOVA, Martin SMRČKA, Václav VYBÍHAL, Pavel FADRUS, Tomáš KAZDA and Andrea KNIGHT. Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients. In \textit{Brain Tumour Conference 2022, 5-7 September 2022, London}. 2022.
|
